EcoR1 Capital, an up-and-coming hedge fund firm focused on biotechnology, is raising a venture capital fund, according to a regulatory filing.
The firm is seeking capital for the EcoR1 Venture Opportunity Offshore Fund, the filing shows. The minimum investment is $2 million.
EcoR1, founded by Oleg Nodelman in 2012, invests in biotech companies that are developing “promising new solutions for untreated diseases,” according to its website.
